Examining the efficacy of verteporfin photo-dynamic therapy (PDT) at different dose & fluence levels
Authors:
- 17 October 2023
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 44, 103848
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Photodynamic therapy for polypoidal choroidal vasculopathyProgress in Retinal and Eye Research, 2013
- Central Serous Chorioretinopathy: Update on Pathophysiology and TreatmentSurvey of Ophthalmology, 2013
- Photodynamic therapy for retinal capillary hemangiomaEye, 2013
- Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular DegenerationOphthalmology, 2012
- Prospective Clinical Trial Evaluating the Efficacy of Photodynamic Therapy for Symptomatic Circumscribed Choroidal HemangiomaOphthalmology, 2009
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR StudyOphthalmology, 2009
- Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous ChorioretinopathyOphthalmology, 2008
- TRIPLE THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATIONRetina, 2007
- Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2005
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999